Thymic peptides and preparations: an update
Cordero OJ, Piñeiro A, Nogueira M. Arch Immunol Ther Exp (Warsz). 1999; 47(2):77–82.
Summarises other people's work. Generates no new data.
Where this design sits
- Cells in a dish
- Animals
- Small human report
- Controlled human trial
- Pooled analysis
This is a review: it summarises other people's work and generates no new data, so it is not placed on the ladder.
- Who or what was studied
- Literature on thymic peptides and thymus preparations up to 1999
- Design
- Narrative review
What it found
A 1999 overview of thymic peptides and preparations. Its abstract says only that the possible human uses were still being worked out, and that the paper covers the peptides' general characteristics and recent advances.
What it doesn’t show
The abstract reports no results, so nothing here shows that any thymic peptide works in people. It is a narrative review from 1999 and cannot reflect later trials.
Funding and conflicts of interest
No funding or conflict-of-interest statement appears in the PubMed record. Check the full text.
Summary written from the study's abstract and checked against PubMed on November 9, 2026. How we check studies. Educational information, not medical advice.
Related studies
- Thymic peptides for treatment of cancer patients (Wolf et al., 2011)
- Effect of Thymalin on the Tumor and Thymus under Conditions of Activation Therapy In Vivo (Zhukova et al., 2018)
- Thymosin Alpha1-Fc Modulates the Immune System and Down-regulates the Progression of Melanoma and Breast Cancer with a Prolonged Half-life (Wang et al., 2018)